BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9824137)

  • 41. Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy.
    Yeo W; Zhong S; Chan PK; Ho WM; Wong HT; Chan AS; Johnson PJ
    J Viral Hepat; 2000 Nov; 7(6):448-58. PubMed ID: 11115057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential accumulation of the basal core promoter and the precore mutations in the progression of hepatitis B virus-related chronic liver disease.
    Song BC; Cui XJ; Kim HU; Cho YK
    Intervirology; 2006; 49(5):266-73. PubMed ID: 16714855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy.
    Cho SW; Hahm KB; Kim JH
    Hepatology; 2000 Nov; 32(5):1163-9. PubMed ID: 11050070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.
    Wang XL; Ren JP; Wang XQ; Wang XH; Yang SF; Xiong Y
    World J Gastroenterol; 2016 Mar; 22(11):3268-74. PubMed ID: 27004005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphism of precore region of hepatitis B virus DNA among patients with chronic HBV infection in Turkey.
    Bozdayi AM; Bozkaya H; Türkyilmaz A; Aslan N; Verdi H; Kence A; Uzunalimoglu O
    Infection; 1999; 27(6):357-60. PubMed ID: 10624597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nucleotide sequence analysis of the hepatitis B virus X-precore region in chronic hepatitis B].
    Li W
    Fukuoka Igaku Zasshi; 2001 Jun; 92(6):225-35. PubMed ID: 11494582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of basal core promoter and precore mutations in chronic hepatitis B.
    Ozgenc O; Ozacar T; Erensoy S; Inan N; Ari A; Kuruuzum Z; Bilgic A
    Hepatogastroenterology; 2007 Dec; 54(80):2319-23. PubMed ID: 18265656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.
    Yuan J; Zhou B; Tanaka Y; Kurbanov F; Orito E; Gong Z; Xu L; Lu J; Jiang X; Lai W; Mizokami M
    J Clin Virol; 2007 Jun; 39(2):87-93. PubMed ID: 17451999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conservation of precore and core sequences of hepatitis B virus in chronic viral carriers.
    Hawkins AE; Gilson RJ; Bickerton EA; Tedder RS; Weller IV
    J Med Virol; 1994 May; 43(1):5-12. PubMed ID: 8083648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
    Abbas Z; Muzaffar R; Siddiqui A; Naqvi SA; Rizvi SA
    BMC Gastroenterol; 2006 Jul; 6():20. PubMed ID: 16863587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
    Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
    Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in the basal core promoter and precore/core gene of hepatitis B virus in patients with chronic active but not acute hepatitis B.
    Mayerat C; Mantegani A; Spertini F; Frei PC
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):871-8. PubMed ID: 10691198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
    Shinkai N; Tanaka Y; Ito K; Mukaide M; Hasegawa I; Asahina Y; Izumi N; Yatsuhashi H; Orito E; Joh T; Mizokami M
    J Clin Microbiol; 2007 Oct; 45(10):3191-7. PubMed ID: 17652471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.
    Fujiwara K; Yokosuka O; Ehata T; Chuang WL; Imazeki F; Saisho H; Omata M
    Dig Dis Sci; 1998 Feb; 43(2):368-76. PubMed ID: 9512133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of core promotor and precore mutants of hepatitis B virus in thailand by RFLP and sequencing.
    Theamboonlers A; Tangkijvanich P; Jantaradsamee P; Hirsch P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):750-5. PubMed ID: 10928370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus harboring nucleotide deletions in the core promoter region and genotype B correlate with low viral replication activity in anti-HBe positive carriers.
    Li KS; Yamashiro T; Sumie A; Terao H; Mifune K; Nishizono A
    J Clin Virol; 2001 Dec; 23(1-2):97-106. PubMed ID: 11595588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
    Zhang K; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O
    J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
    Kamijo N; Matsumoto A; Umemura T; Shibata S; Ichikawa Y; Kimura T; Komatsu M; Tanaka E
    World J Gastroenterol; 2015 Jan; 21(2):541-8. PubMed ID: 25593470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus.
    Ledesma MM; Galdame O; Bouzas B; Tadey L; Livellara B; Giuliano S; Viaut M; Paz S; Fainboim H; Gadano A; Campos R; Flichman D
    Int J Infect Dis; 2011 May; 15(5):e314-20. PubMed ID: 21367634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.